Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

XBIXBI
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in SPDR S&P BIOTECH ETF

GOLDMAN SACHS GROUP INC holds 15.1M shares of XBI (SPDR S&P BIOTECH ETF), worth $2.4B as of 2026-Q2. The position was increased (+10.2% shares). XBI represents 0.2% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$2.4B

Current Shares

15.1M

Total Value Change

+$1.5B

Total Shares Change

+5.6M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
15.1M
+10.2%
$2.4B0.2%$158.25
42
2026-Q1
Decreased
13.7M
-31.1%
$1.8B0.2%$123.50
0
2025-Q4
Decreased
19.9M
-12.5%
$2.4B0.3%$121.67
0
2025-Q3
Increased
22.7M
+25.6%
$2.3B0.3%$99.07
47
2025-Q2
Increased
18.1M
+38.1%
$1.5B0.2%$82.71
50
2025-Q1
Increased
13.1M
+37.1%
$1.1B0.2%$84.09
50
2024-Q4
New
9.6M
-
$860.5M0.1%$89.56
53

Other major holders of XBI: BNP PARIBAS FINANCIAL MARKETS, Steward Partners Investment Advisory, LLC, JPMORGAN CHASE & CO

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used